Word

SYNBIOFF

Status

Registered

Status Code

700

Status Date

Tuesday, November 21, 2023

Serial Number

79338517

Registration Number

7220430

Registration Date

Tuesday, November 21, 2023

Mark Type

4000

Filing Date

Tuesday, March 1, 2022

Published for Opposition

Tuesday, September 5, 2023

Trademark Owner History

SYNBALANCE SRL - Original Registrant

Classifications

5 Probiotic bacterial formulations for medical use; probiotic supplements; pharmaceutical and medicinal preparations for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical and medicinal preparations for use in the treatment of gastro-intestinal, immunity and uro-genital disorders, hyperlipidemia, sunburn, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, damaged skin and tissue, eye diseases and conditions, skin disorders, diabetes, erectile dysfunction, bone diseases, immune system related diseases and disorders, allergies, hypertension, epidermis, respiratory diseases, cardiovascular disorders, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, respiratory diseases, asthma, allergic rhinitis, viral infections, gastro-intestinal diseases, halitosis, viral diseases, autoimmune diseases; pharmaceutical preparations for skin care; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention of gastro-intestinal and urogenital infections, seasonal illness, common colds, cardiovascular disease, gastro-intestinal or local dysbiosis, allergies; pharmaceutical preparations for wounds; pharmaceutical preparations for animal skincare; pharmaceutical preparations acting on the central nervous system; dermatological pharmaceutical products; pharmaceutical skin lotions; pharmaceutical products for skin care for animals; anti-diabetic pharmaceuticals; ferments for pharmaceutical purposes; pharmaceutical agents affecting metabolism; ferments for pharmaceutical purposes, namely, for gastro-intestinal, immunity and uro-genital disorders; digestives for pharmaceutical purposes; pharmaceutical preparation for skin care; pharmaceuticals, namely, lipid lowering agents; milk ferments for pharmaceutical purposes

1 Probiotic bacteria for use in the manufacture of pharmaceuticals and nutraceuticals

Trademark Events

Mar 18, 2024

Final Decision Transaction Processed By Ib

Feb 22, 2024

Final Disposition Notice Sent To Ib

Feb 22, 2024

Final Disposition Processed

Feb 21, 2024

Final Disposition Notice Created, To Be Sent To Ib

Nov 21, 2023

Notice Of Registration Confirmation Emailed

Nov 21, 2023

Registered-Principal Register

Oct 16, 2023

Notification Of Possible Opposition - Processed By Ib

Sep 27, 2023

Notification Of Possible Opposition Sent To Ib

Sep 27, 2023

Notification Of Possible Opposition Created, To Be Sent To Ib

Sep 5, 2023

Official Gazette Publication Confirmation E-Mailed

Sep 5, 2023

Published For Opposition

Sep 4, 2023

Notification Processed By Ib

Aug 16, 2023

Notification Of Possible Opposition Sent To Ib

Aug 16, 2023

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Aug 16, 2023

Notification Of Notice Of Publication E-Mailed

Jul 28, 2023

Approved For Pub - Principal Register

Jul 27, 2023

Teas/Email Correspondence Entered

Jul 26, 2023

Correspondence Received In Law Office

Jul 26, 2023

Teas Response To Office Action Received

May 27, 2023

New Representative At Ib Received

May 14, 2023

New Representative At Ib Received

Mar 15, 2023

Refusal Processed By Ib

Feb 22, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Feb 22, 2023

Refusal Processed By Mpu

Dec 27, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Dec 26, 2022

Non-Final Action Written

Dec 13, 2022

Assigned To Examiner

Apr 26, 2022

Application Filing Receipt Mailed

Apr 22, 2022

New Application Office Supplied Data Entered

Apr 21, 2022

Sn Assigned For Sect 66a Appl From Ib